Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Research Field Gene Editing, Policy

It's CRISPR Crunch Time

On 26 February, 2019 – four months on from that bombshell (He Jiankui’s gene-edited babies) – China’s health ministry released a draft set of regulations for public consultation. Meanwhile, the World Health Organization (WHO) has established an advisory committee tasked with developing global standards for the governance and oversight of human genome editing (1); on March 19, 2019, the WHO met in Geneva, Switzerland, to discuss how to proceed.

Unsurprisingly, He’s wrongdoing has whipped up something of a regulatory frenzy. But will the implementation of a stricter set of rules and respective punishments for their violation deter other scientists from following in his footsteps?

Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Jonathan James

As an assistant editor for The Translational Scientist, I can combine two of my passions; translational science research and science communication. Having thrown myself into various editing and other science communication gigs whilst at University I came to realise the importance of good quality content that delivers in an exciting and engaging way.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register